Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin

Autor: Robert Hüneburg, Helge Martens, Martin Stangel, Andreas Erbersdobler, Wiebke Ewert, Matthias Preller, Stephan Wolf, Ruthild G. Weber, Bettina Wiese, Amir Samii, Natalie Elyan, Christopher Previti, Joachim K. Krauss, Stefan Aretz, Rouzbeh Banan, Ulrike Beyer, Bujung Hong, Christine A. M. Weber, Jan Hinrich Bräsen, Frank Brand, Alisa Förster, Jessica Kronenberg, Christian Hartmann
Rok vydání: 2021
Předmět:
Zdroj: Acta Neuropathologica
Acta Neuropathol (2021) 142:191–210
ISSN: 1432-0533
0001-6322
DOI: 10.1007/s00401-021-02307-1
Popis: The genetic basis of brain tumor development is poorly understood. Here, leukocyte DNA of 21 patients from 15 families with ≥ 2 glioma cases each was analyzed by whole-genome or targeted sequencing. As a result, we identified two families with rare germline variants, p.(A592T) or p.(A817V), in the E-cadherin gene CDH1 that co-segregate with the tumor phenotype, consisting primarily of oligodendrogliomas, WHO grade II/III, IDH-mutant, 1p/19q-codeleted (ODs). Rare CDH1 variants, previously shown to predispose to gastric and breast cancer, were significantly overrepresented in these glioma families (13.3%) versus controls (1.7%). In 68 individuals from 28 gastric cancer families with pathogenic CDH1 germline variants, brain tumors, including a pituitary adenoma, were observed in three cases (4.4%), a significantly higher prevalence than in the general population (0.2%). Furthermore, rare CDH1 variants were identified in tumor DNA of 6/99 (6%) ODs. CDH1 expression was detected in undifferentiated and differentiating oligodendroglial cells isolated from rat brain. Functional studies using CRISPR/Cas9-mediated knock-in or stably transfected cell models demonstrated that the identified CDH1 germline variants affect cell membrane expression, cell migration and aggregation. E-cadherin ectodomain containing variant p.(A592T) had an increased intramolecular flexibility in a molecular dynamics simulation model. E-cadherin harboring intracellular variant p.(A817V) showed reduced β-catenin binding resulting in increased cytosolic and nuclear β-catenin levels reverted by treatment with the MAPK interacting serine/threonine kinase 1 inhibitor CGP 57380. Our data provide evidence for a role of deactivating CDH1 variants in the risk and tumorigenesis of neuroepithelial and epithelial brain tumors, particularly ODs, possibly via WNT/β-catenin signaling.
Databáze: OpenAIRE
Externí odkaz: